2,014
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Metabolomic assessment of mechanisms underlying anti-renal fibrosis properties of petroleum ether extract from Amygdalus mongolica

, , , , , , & show all
Pages 563-572 | Received 27 Aug 2020, Accepted 18 Apr 2021, Published online: 14 May 2021

References

  • Bai WF, Shi SL, Zhou HB, Zhang Y. 2015. Comparison of contents of amygdalin in Amygdalus mongolica seed from different producing area. Chin J Health Lab Technol. 25:315–317.
  • Boor P, Ostendorf T, Floege J. 2010. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol. 6(11):643–656.
  • Buriani A, Garcia-Bermejo ML, Bosisio E, Xu Q, Li H, Dong X, Simmonds MS, Carrara M, Tejedor N, Lucio-Cazana J, et al. 2012. Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future. J Ethnopharmacol. 140(3):535–544.
  • Chang H, Liu Q, Bai W-F, Bai Y-C, Jia X-Y, Gao C, Liu Q-L, Shi S-L, Zhou H-B. 2020. Protective effects of Amygdalus mongolica on rats with renal fibrosis based on serum metabolomics. J Ethnopharmacol. 257:112858.
  • Chen F, Lu ZW, Dai EL. 2016. Research progress of Chinese and Western medicine pathogenesis of renal fibrosis. J Liaoning Univ Trad Chin Med. 43:1243–1246.
  • Ellison DH. 2017. Treatment of disorders of sodium balance in chronic kidney disease. Adv Chronic Kidney Dis. 24(5):332–341.
  • Gülçin I. 2007. Comparison of in vitro antioxidant and antiradical activities of l-tyrosine and l-dopa. Amino Acids. 32(3):431–438.
  • Han WC. 2014. Protection mechanisms of EPA on renal tubular epithelial cells injury stimulated by albumin [Master’s thesis]. Shandong (CHN): Shandong University.
  • Hao HM, Jia XY, Zhou HB, Bai WF, Chang H, Shi SL. 2020. Investigation of the anti-renal fibrosis effect of Amygdalus mongolica using metabonomics. Acta Pharm Sin. 55:2182–2190.
  • He WM, Liu BH, Gao K, Zhou D, Sheng MX, Zhang L, Jiang Y, Li ZH, Sun W. 2018. Research progress of Chinese medicine in the treatment of renal fibrosis. J Nanjing Univer of Trad Chin Med. 34:112–117.
  • Ji J, He LQ. 2018. Prevention and treatment of renal fibrosis with integrated traditional Chinese and Western medicine. Chin J Exper Trad Med Formulae. 24:221–228.
  • Jia XY, Gao C, Liu Q, Shi SL, Zhou HB, Bai YC, Bai WF, Chang H. 2020. Screening of effective parts of Mongolian Amygdala against renal fibrosis in rats. Sci Technol Food Ind. 41:297–302.
  • Li SS, Xiao X, Han L, Li L, Wang YM, Luo GA. 2012. Influence of zhenwu decoction on the activity of total superoxidedismutase activity and the concentration of MDA in serum and kidney of renal fibrosis rat. Pharmacol Clin Chin Materia Med. 28:19–21.
  • Lijnen HR. 2005. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost. 3(1):35–45.
  • Lyu S, Yang SL, Rao Y, Feng YL. 2018. Application of metabolomics and related technologies in research and development field of traditional Chinese medicine. China J Chin Materia Med. 43:4182–4191.
  • Ma YQ. 1989. Flora of Inner Mongolia. Vol. 3. Hohhot: Inner Mongolia People's Publishing House; p. 519–522.
  • Ma YY, Liu CH, Tao YY. 2018. Research progress of animal models of renal fibrosis and their characteristics. Acta Lab Animalis Sci Sin. 26:398–403.
  • Nogueira A, Pires MJ, Oliveira PA. 2017. Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies. In Vivo. 31(1):1–22.
  • Orchard TJ, Forrest KY, Kuller LH, Becker DJ. 2001. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. (6)24:1053–1059.
  • Øvrehus MA, Bruheim P, Ju W, Zelnick LR, Langlo KA, Sharma K, de Boer IH, Hallan SI. 2019. Gene expression studies and targeted metabolomics reveal disturbed serine, methionine, and tyrosine metabolism in early hypertensive nephrosclerosis. Kidney Int Rep. (2)4:321–333.
  • Qi L, Yi T, Wang XN, Liu P., Liu CH 2014. A study on regularity of compound herbal formulae for renal fibrosis based on literature. Chin J Info Trad Chin Med. 21:34–37.
  • Schmitt R. 2012. Mechanisms of renal fibrosis. Nephrologe. (1)7:10–17.
  • Shi SL, Bai YC, Zhou HB, Niu SF. 2013. Extraction and determination of content of polysaccharides in Amygdalus mongolica. Lishizhen Med Materia Med Res. 24:257–258.
  • Shi SL, Niu SF, Wang DK, Cheng XH, Bai YC. 2013. Determination of trace elements in medicinal materials of Prunus mongolica by ICP-AES. Chinese J Exper Trad Med Formulae. 19:74–77.
  • Si Q. 2003. Amygdalus mongolica. Bull Biol. 38:23–24.
  • Su K, Shi SL, Zheng DH, Li JX. 2013. Determination of alpha tocopherol content in Amygdalus mongolica by HPLC. Chin J Exper Trad Med Formulae. 19:70–72.
  • Wang X, Wang T, Zhang C, Liu F, Fu CM. 2019. Study on influence of Magnolia officinalis before and after "sweating" on gastrointestinal motility disorder in rats by metabolomics. China J Chin Materia Med. 44:1170–1178.
  • Wang XM, Yang LX, Song WZ, Qi F, Guo CM, Shi YK, Zhao Y, Wei L, Wang Y. 2006. Effect of benazepril on renal fibrosis in spontaneously hypertensive rats. Negative. 20:1859–1862.
  • Wu T, Chang H, Shi SL, Zhou HB, Wu PS, Zheng QN, He X. 2017. Effect of petroleum ether extracts of Amygdalus mongolica on liver fibrosis rat models induced by carbon tetrachloride. Chin Arch Trad Chin Med. 35:595–598.
  • Wu XY, Li LY, Wang YQ, Wang GM, Li XF, Dong FX. 2017. The protective effect of Qing-Hua-Gu-Shen-Pai-Du Granuleson expression of Col-IVand FN in UUO rats. Chin Arch Trad Chin Med. 35:2115–2117.
  • Xiao J, Zhang HL, Xu MQ, Xiao Y, Zhang LJ, He JY. 2015. Effects of Cordyceps sinensis powder on proline content and P21 expression in renal tissue of rats with obstructive renal disease. Chin J Biomed Eng. 21:319–324.
  • Xue H, Fan JM, Chen L, Su BH, Li Z, Hu ZX, Liu XR, Xu GZ. 2004. Investigation of renal fibrosis induced by unilateral ureteral obstruction. Sichuan J Zool. 23:16–20.
  • Zhang AG, Gw QF, Wu M. 2013. Advances in the study of renal protection of Benapril in patients with hypertension. Hebei Med J. 35:755–756.
  • Zhang YZ. 2013. Research progress in clinical application of dopamin. Chin J Difficult Complicated Cases. 12:401–403.
  • Zhang ZH, Li MH, Liu D, Chen H, Chen DQ, Tan NH, Ma SC, Zhao YY. 2018. Rhubarb protect against tubulointerstitial fibrosis by inhibiting TGF-β/smad pathway and improving abnormal metabolome in chronic kidney disease. Front Pharmacol. 9:1014–1029.
  • Zhao YL, Yang JQ, Zhang L, Fu P. 2013. New anti-inflammatory agent resolvins and kidney disease. Chin J Nephrol, Dialysis Transplant. 22:268–271.
  • Zhao YZ. 1995. Study on floristic geographical distribution of Amygdalus mongolica. J Inner Mongolia Univ. (Nat Sci Ed). 26:713–715.
  • Zheng DH, Shi SL, Su K. 2013. Determination of content of organic acids in Prunus mongolica. Lishizhen Med Materia Med Res. 24:515–516.
  • Zheng QN, Shi SL, Zhou HB, Wu PS, Wu T, He X, Wang DK. 2016. Effects of petroleum ether extract of Mongolian Amygdala on lipid level, liver function and lipid peroxidation in hyperlipidemia rats. Pharmacol Clin Chin Materia Med. 32:67–70.
  • Zheng QN, Su K, Shi SL, Zhou HB, Cheng XH, Bai YC, Wang DK. 2018. Components analysis, dose-effect relationship and antioxidation of the petroleum ether extracted from Amygdalus mongolica. China J Trad Chin Med Pharm. 33:287–290.
  • Zheng QN, Wang J, Zhou HB, Niu SF, Liu QL, Yang ZJ, Wang H, Zhao YS, Shi SL. 2017. Effectiveness of Amygdalus mongolica oil in hyperlipidemic rats and underlying antioxidant processes. J Toxicol Envir Health A. (22)80:1193–1198.
  • Zhou BH, Zhou J, Liang YX, Yi HL, Wu Y, Liu G. 2014. Effects of tannins in pomegranate bark on endogenous metabolites in rats with renal fibrosis. Chin J Hosp Pharm. 34:2009–2013.
  • Zhou SD, Zheng FY. 1960. Observation on the effect of nephritis in 22 cases. Fujian J Trad Chin Med. 9:9–11.